| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc. | SVP, Finance and CAO | Common Shares | 0 | $0 | $2.60 | 28 Jan 2026 | Direct |
| Repare Therapeutics Inc. | SVP, Finance and CAO | Employee Stock Option (right to buy) | 0 | 28 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RPTX | Repare Therapeutics Inc. | 28 Jan 2026 | 3 | $0 | 4 | SVP, Finance and CAO | 28 Jan 2026, 20:30 |
| RPTX | Repare Therapeutics Inc. | 02 Apr 2025 | 2 | $0 | 4 | SVP, Finance and CAO | 29 Apr 2025, 17:07 |
| RPTX | Repare Therapeutics Inc. | 31 Mar 2025 | 0 | $0 | 3 | SVP, Finance and CAO | 29 Apr 2025, 17:05 |